Blood donor screening for chagas disease - United States, 2006-2007

Morbidity and Mortality Weekly Report

Volumn 56, Issue 7, 2007, Pages 141-143

  Stramer, S L ^a   Dodd, R Y ^a   Leiby, D A ^a   Herron, R M ^a   Mascola, L ^b   Rosenberg, L J ^c   Lawaczeck, E ^d   Sunenshine, R H ^d   Kuehnert, M J ^e   Montgomery, S ^f   Bern, C ^f   Moore, A ^f   Herwaldt, B ^f   Kun, H ^g   Verani, J R ^g  

^a AMERICAN RED CROSS   (United States)

^b Los Angeles County Department of Public Health   (United States)

^c Blood Systems Laboratories   (United States)

^d Arizona Dept of Health Svcs   (United States)

^e Detection   (United States)

^f National Center for Zoonotic Vector Borne and Enteric Diseases

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOON ANTIBODY;

ANIMAL; ARTICLE; BLOOD; BLOOD BANK; BLOOD DONOR; CHAGAS DISEASE; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; ISOLATION AND PURIFICATION; RADIOIMMUNOPRECIPITATION; TRYPANOSOMA CRUZI; UNITED STATES;

ANIMALS; ANTIBODIES, PROTOZOAN; BLOOD BANKS; BLOOD DONORS; CHAGAS DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; RADIOIMMUNOPRECIPITATION ASSAY; TRYPANOSOMA CRUZI; UNITED STATES;

EID: 33847278515     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. WHO Expert Committee. Control of Chagas disease. World Health Organ Tech Rep Ser 2002;905:i-vi,1-109.
2. Herwaldt BL, Grijalva MJ, Newsome AL, et al. Use of polymerase chain reaction to diagnose the fifth reported US case of autochthonous transmission of Trypanosoma cruzi, in Tennessee, 1998. J Infect Dis 2000;181:395-9.
3. Cimo PL, Luper WE, Scouros MA. Transfusion-associated Chagas' disease in Texas: report of a case. Tex Med 1993;89:48-50.
4. Lane DJ, Sher G, Ward B, Ndao M, Leiby D, Hewlett B. Investigation of the second case of transfusion transmitted Chagas disease in Canada. Presented at: 42nd Annual Meeting of the American Society of Hematology, San Francisco, California; December 1-5, 2000.
5. Leiby DA, Lenes BA, Tibbals MA, Tames-Olmedo MT. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999;341:1237-9.
6. Saulnier Sholler GL, Kalkunte S, Greenlaw C, McCarten K, Forman E. Antitumor activity of nifurtimox observed in a patient with neuroblastoma. J Pediatr Hematol Oncol 2006;28:693-5.
7. Leiby DA, Herron RM Jr, Read EJ, Lenes BA, Stumpf RJ. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002;42:549-55.
8. Food and Drug Administration. Product approval information licensing action. ORTHO T. cruzi ELISA Test System. Available at http://www.fda.gov/cber/products/tryorth121306.htm.
9. Tobler LH, Contestable P, Pitina L, et al. Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors. Transfusion 2007;47:90-6.
10. Leiby DA, Wendel S, Takaoka DT, Fachini RM, Oliveira LC, Tibbals MA. Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits. J Clin Microbiol 2000;38:639-42.